<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 15. Summary of Drug Interactions With Lamotrigine</caption>
<col width="34%"></col>
<col width="31.5%"></col>
<col width="34.5%"></col>
<tbody>
<tr>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     "> Drug</td>
<td align="center" stylecode="     Botrule          Rrule     "> Drug Plasma Concentration With Adjunctive Lamotrigine<footnote id="FOOT_5949">From adjunctive clinical trials and volunteer studies.</footnote>
</td>
<td align="center" stylecode="     Botrule          Rrule     "> Lamotrigine Plasma Concentration With Adjunctive Drugs<footnote id="FOOT_5950">Net effects were estimated by comparing the mean clearance values obtained in adjunctive clinical trials and volunteers studies.</footnote>
</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> Oral contraceptives (e.g., ethinylestradiol/levonorgestrel)<footnote id="FOOT_5951">The effect of other hormonal contraceptive preparations or hormone replacement therapy on the pharmacokinetics of Lamotrigine has not been systematically evaluated in clinical trials, although the effect may be similar to that seen with the ethinylestradiol/levonorgestrel combinations.</footnote>
</td>
<td align="center" stylecode="     Rrule     "> ↔<footnote id="FOOT_5952">Modest decrease in levonorgestrel.</footnote>
</td>
<td align="center" stylecode="     Rrule     "> ↓</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> Bupropion</td>
<td align="center" stylecode="     Rrule     "> Not assessed</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> Carbamazepine (CBZ)</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
<td align="center" stylecode="     Rrule     "> ↓</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> CBZ epoxide<footnote id="FOOT_5953">Not administered, but an active metabolite of carbamazepine.</footnote>
</td>
<td align="center" stylecode="     Rrule     "> ?</td>
<td align="center" stylecode="     Rrule     "> </td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> Felbamate</td>
<td align="center" stylecode="     Rrule     "> Not assessed</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> Gabapentin</td>
<td align="center" stylecode="     Rrule     "> Not assessed</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> Levetiracetam</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> Lithium</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
<td align="center" stylecode="     Rrule     "> Not assessed</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> Olanzapine</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
<td align="center" stylecode="     Rrule     "> ↔<footnote id="FOOT_5954">Slight decrease, not expected to be clinically relevant.</footnote>
</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> Oxcarbazepine</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> 10-monohydroxy oxcarbazepine metabolite<footnote id="FOOT_5955">Not administered, but an active metabolite of oxcarbazepine.</footnote>
</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
<td align="center" stylecode="     Rrule     "> </td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> Phenobarbital/primidone</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
<td align="center" stylecode="     Rrule     "> ↓</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> Phenytoin (PHT)</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
<td align="center" stylecode="     Rrule     "> ↓</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> Pregabalin</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> Rifampin</td>
<td align="center" stylecode="     Rrule     "> Not assessed</td>
<td align="center" stylecode="     Rrule     "> ↓</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> Topiramate</td>
<td align="center" stylecode="     Rrule     "> ↔<footnote id="FOOT_5956">Slight increase not expected to be clinically relevant.</footnote>
</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> Valproate</td>
<td align="center" stylecode="     Rrule     "> ↓</td>
<td align="center" stylecode="     Rrule     "> ↑</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     "> Valproate + PHT and/or CBZ</td>
<td align="center" stylecode="     Rrule     "> Not assessed</td>
<td align="center" stylecode="     Rrule     "> ↔</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     "> Zonisamide</td>
<td align="center" stylecode="     Botrule          Rrule     "> Not assessed</td>
<td align="center" stylecode="     Botrule          Rrule     "> ↔</td>
</tr>
<tr>
<td colspan="3" valign="top"> ↔ = No significant effect.<br/>? = Conflicting data.</td>
</tr>
</tbody>
</table>